Golden logo
    Create a WorkspaceQuery ToolSaved QueriesData RequestsListsPipelinesExploreFollowed Topics
    Upgrade to ProPricingAPI AccessHelp & Support
Log in
Sign up
NEW: You can now make knowledge queries using our new natural language prompt. Try it out now!
⟶
Siolta Therapeutics

Siolta Therapeutics

Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.

OverviewStructured DataIssuesContributorsActivity
Contents

Siolta Therapeutics is a privately held, venture-backed biotechnology company based in San Carlos, California. It focuses on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

The company's lead product candidate is a therapeutic developed from gut microbiome for the prevention and treatment of allergic asthma. The product is also being explored for the treatment of other allergic conditions such as seasonal allergy, food allergy, and atopic dermatitis. Phase 1 clinical trials are ongoing for these target conditions. Future plans also include the development of therapeutics for other chronic inflammatory diseases.

Siolta Therapeutics' mission in regards to developing solutions against inflammatory diseases include creating novel microbiome-based medicines and treatments. They are interested in the researching microbiome of infants and promoting immune tolerances for the purpose of preventing and treating inflammatory diseases.

The most genetic information encoded across microbial life occurs in the gut for humans, where various immune cells also reside. When these two life forms interact, microbiome developments occur, which can cause immune dysfunctions. Siolta's goal is to understand the interactions that take place in order to promote healthy developments and prevent dysfunctions.

Timeline

November 23, 2020
Microbiome Dx company Bio-Me and Siolta Therapeutics announce that they have entered into a collaboration and marketing agreement.
September 22, 2020
Siolta Therapeutics raises a $30,000,000 series B round.
2016
Siolta Therapeutics was founded by Nikole Kimes PhD and Susan Lynch PhD.

Funding Rounds

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

References

sioltatherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Microbiome
Microbiome
Therapeutics
Therapeutics
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Diagnosis
Diagnosis
...
Location
San Carlos, California
San Carlos, California
B2X
B2C
B2C
CEO
‌
Nikole Kimes PhD
Founder
‌
Nikole Kimes PhD
‌
Susan Lynch PhD
Date Incorporated
2016
Full Address
930 Brittan Ave. San Carlos, CA 94070
Investors
Seventure Partners
Seventure Partners
Founded Date
2016
Email Address
info@sioltatherapeutics.com
Phone Number
+14159910947
Total Funding Amount (USD)
30,000,000
Latest Funding Round Date
September 22, 2020
Glassdoor ID
1919526
Latest Funding Type
Series B round
Series B round
Wellfound ID
siolta-therapeutics

Other attributes

Company Operating Status
Active
Country
United States
United States
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
OverviewKnowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseProtocol
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.